We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Novo Nordisk A/S won't be able to get a preliminary injunction to block sales of Pfizer Inc.'s Exubera inhalable insulin before Pfizer's planned launch of the product in September.
Hospira Inc., a maker of specialty pharmaceuticals and drug delivery systems for hospitals, said that Thomas E. Werner will become company's new chief financial officer.
Gilead Sciences Inc. agreed to a manufacturing and distribution deal for the HIV drug Atripla with Merck & Co. Foster City-based Gilead will make the tablets a combination of three HIV drugs in one pill using one of the drugs, efavirenz, supplied by Merck.
A long-scheduled showdown between Merck & Co. and Teva Pharmaceuticals USA Inc. over rights to once-weekly formulations of osteoporosis treatments has been taken off the calendar of a federal court.
Drug makers Schering-Plough Corp. and Novartis AG said Monday they will collaborate on a combination inhalation therapy to treat asthma and chronic obstructive pulmonary disease.
Teva Pharmaceutical Industries Ltd. announced that it has begun the sale of its generic version of Pfizer's Zoloft (Sertraline) Tablets, 25 mg, 50 mg, and 100 mg in the United States.
A federal appeals court has affirmed a lower court decision that an anemia drug co-developed by Aventis Pharmaceuticals and Transkaryotic Therapies (TKT) infringes on Amgen's patents for its anemia drug Epogen.
Sen. Chuck Grassley (R-Iowa), a frequent critic of the FDA's drug safety policies, is considering expanding his investigation into compounding following lobbying by activist groups.